Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fallon

Showing results (231-240 of 235) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 235 results.
Cell Metabolism|March 2, 2022
Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophagesMarah C Runtsch, Stefano Angiari, Alexander Hooftman, et al.
Journal of Thrombosis and Haemostasis : JTH|February 12, 2023
Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factorEinas Elsheikh, Michelle Lavin, Lilian Antunes Heck, et al.
The Journal of Allergy and Clinical Immunology|October 3, 2013
Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjectsSean P Saunders, Christabelle S M Goh, Sara J Brown, et al.
Nature|March 29, 2018
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1Evanna L Mills, Dylan G Ryan, Hiran A Prag, et al.
Nature Communications|June 14, 2023
Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I InterferonTristram A J Ryan, Alexander Hooftman, Aisling M Rehill, et al.
Pageof 24

Showing results (231-240 of 235) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 235 results.
Cell Metabolism|March 2, 2022
Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophagesMarah C Runtsch, Stefano Angiari, Alexander Hooftman, et al.
Journal of Thrombosis and Haemostasis : JTH|February 12, 2023
Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factorEinas Elsheikh, Michelle Lavin, Lilian Antunes Heck, et al.
The Journal of Allergy and Clinical Immunology|October 3, 2013
Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjectsSean P Saunders, Christabelle S M Goh, Sara J Brown, et al.
Nature|March 29, 2018
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1Evanna L Mills, Dylan G Ryan, Hiran A Prag, et al.
Nature Communications|June 14, 2023
Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I InterferonTristram A J Ryan, Alexander Hooftman, Aisling M Rehill, et al.
Pageof 24